L. Serra, R. Perri, G. Carlesimo, L. Fadda, S. Lorusso, A. Padovani, C. Pettenati, Maia Vegliante, C. Caltagirone
{"title":"ADAS-CoG和精神退化电池:不同的仪器用于阿尔茨海默病认知能力下降的不同方面","authors":"L. Serra, R. Perri, G. Carlesimo, L. Fadda, S. Lorusso, A. Padovani, C. Pettenati, Maia Vegliante, C. Caltagirone","doi":"10.1002/NRC.20032","DOIUrl":null,"url":null,"abstract":"Objective: Aim of this study was to compare ADAS-Cog and MDB, instruments usually used in cognitive assessment of AD patients, relative to: 1) diagnostic sensitivity for dementia of AD; 2) ability to rate the progression of cognitive decline and ability to detect the qualitative characteristics of cognitive decline. Material and methods: A sample of 54 AD patients was submitted to a cognitive assessment with both battery at time of study entry (T 0) and after 12 months (T 12). Results: This study showed: 1) a better diagnostic sensitivity of MDB respect to ADAS-Cog in diagnosing patients affected by mild to moderate levels of AD; 2) a better sensitivity of ADAS-Cog to follow the cognitive decline over a twelve-months period Conclusion: These results supports the use of the MDB in the screening phase of AD patients and of ADAS-Cog to follow the progression of cognitive decline over time.","PeriodicalId":19198,"journal":{"name":"Neuroscience Research Communications","volume":"10 1","pages":"184-192"},"PeriodicalIF":0.0000,"publicationDate":"2004-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"ADAS-CoG and mental deterioration battery: Different instruments for different aspects of cognitive decline in Alzheimer's disease\",\"authors\":\"L. Serra, R. Perri, G. Carlesimo, L. Fadda, S. Lorusso, A. Padovani, C. Pettenati, Maia Vegliante, C. Caltagirone\",\"doi\":\"10.1002/NRC.20032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: Aim of this study was to compare ADAS-Cog and MDB, instruments usually used in cognitive assessment of AD patients, relative to: 1) diagnostic sensitivity for dementia of AD; 2) ability to rate the progression of cognitive decline and ability to detect the qualitative characteristics of cognitive decline. Material and methods: A sample of 54 AD patients was submitted to a cognitive assessment with both battery at time of study entry (T 0) and after 12 months (T 12). Results: This study showed: 1) a better diagnostic sensitivity of MDB respect to ADAS-Cog in diagnosing patients affected by mild to moderate levels of AD; 2) a better sensitivity of ADAS-Cog to follow the cognitive decline over a twelve-months period Conclusion: These results supports the use of the MDB in the screening phase of AD patients and of ADAS-Cog to follow the progression of cognitive decline over time.\",\"PeriodicalId\":19198,\"journal\":{\"name\":\"Neuroscience Research Communications\",\"volume\":\"10 1\",\"pages\":\"184-192\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2004-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroscience Research Communications\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/NRC.20032\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Research Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/NRC.20032","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
ADAS-CoG and mental deterioration battery: Different instruments for different aspects of cognitive decline in Alzheimer's disease
Objective: Aim of this study was to compare ADAS-Cog and MDB, instruments usually used in cognitive assessment of AD patients, relative to: 1) diagnostic sensitivity for dementia of AD; 2) ability to rate the progression of cognitive decline and ability to detect the qualitative characteristics of cognitive decline. Material and methods: A sample of 54 AD patients was submitted to a cognitive assessment with both battery at time of study entry (T 0) and after 12 months (T 12). Results: This study showed: 1) a better diagnostic sensitivity of MDB respect to ADAS-Cog in diagnosing patients affected by mild to moderate levels of AD; 2) a better sensitivity of ADAS-Cog to follow the cognitive decline over a twelve-months period Conclusion: These results supports the use of the MDB in the screening phase of AD patients and of ADAS-Cog to follow the progression of cognitive decline over time.